The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor1α promoter
Abstract
For effective gene therapy of chronic disease, persistent transgene expression at therapeutic levels is required. Clinical studies of airway gene transfer in patients with cystic fibrosis (CF) have resulted in short-lived transgene expression. We used intra-nasal dosing of naked plasmid DNA to the murine lung as a model for investigating the duration of airway gene transfer from a series of reporter expression plasmids. Transgene expression was transient when mediated by the viral promoters CMV, RSV and SV40, falling to less than 10% of peak expression after 2 weeks, although the presence of the adenoviral E4ORF3 gene in cis, resulted in extended duration of reporter activity from the CMV promoter. Transient expression from these promoters was not due to loss of the vector as determined by quantitative TaqMan PCR analysis. However, use of the promoters from the human polybiquitin C (UbC) and the elongation factor 1alpha (EF1alpha) genes resulted in persistent gene expression in the mouse lung. The UbC promoter directed high-level reporter activity which was maintained for up to 8 weeks and was still detectable 6 months after a single administration. Such persistent airway transgene expression from a nonviral vector without the concomitant expression of a potential antigen has not been reported previously. Thus, despite the persistence of vector DNA in vivo, attenuation of promoter function may lead to silencing of transgene expression and careful selection of promoter sequenc…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“thus providing the relevant advantage of minimizing the potential risk of on-target chromosomal translocations61.”
From Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing (2019) · cites this paper as [61]
Citations
Cites
Characteristics of a human cell line transformed by DNA from human adenovirus type 5
Graham, F. L., Russell, W. C., Smiley, J., & Nairn, R. (1977) · Journal of General Virology · doi:10.1099/0022-1317-36-1-59 · Cited by 4,793
Kozak, M. (1986) · Cell · doi:10.1016/0092-8674(86)90762-2 · Cited by 4,741
A novel cationic liposome reagent for efficient transfection of mammalian cells
Gao, X., & Huang, L. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91366-k · Cited by 847
Lee, E. R., Marshall, J., Siegel, C., Jiang, C., Yew, N. S., Nichols, M., Nietupski, J. B., Ziegler, R. J., Lane, M. B., Wang, K. X., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.14-1701 · Cited by 443
DNA Methylation and Silencing of Gene Expression
Newell-Price, J. D. C., Clark, A. J. L., & King, P. (2000) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(00)00248-4 · Cited by 330
Qin, L., Ding, Y., Pahud, D. R., Chang, E., Imperiale, M. J., & Bromberg, J. S. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.17-2019 · Cited by 315
Role of covalent modifications of histones in regulating gene expression
Spencer, V. A., & Davie, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00405-9 · Cited by 306
Löser, P., Jennings, G. S., Strauss, M., & Sandig, V. (1998) · Journal of Virology · doi:10.1128/jvi.72.1.180-190.1998 · Cited by 277
Uetsuki, T., Naito, A., Nagata, S., & Kaziro, Y. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)83619-5 · Cited by 272
Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies.
Carvalho, T., Seeler, J.-S., Öhman, K., Jordan, P., Pettersson, U., Akusjärvi, G., Carmo‐Fonseca, M., & Dejean, A. (1995) · The Journal of Cell Biology · doi:10.1083/jcb.131.1.45 · Cited by 267
Cited by
Sorted by citations
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Chen, Z.-Y., He, C.-Y., Ehrhardt, A., & Kay, M. A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00168-0 · Cited by 463
Baldi, L., Hacker, D. L., Adam, M., & Wurm, F. M. (2007) · Biotechnology Letters · doi:10.1007/s10529-006-9297-y · Cited by 328
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression
Hyde, S. C., Pringle, I. A., Abdullah, S., Lawton, A. E., Davies, L. A., Varathalingam, A., Nunez-Alonso, G. A., Green, A.-M., Bazzani, R. P., Jones, S., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1399 · Cited by 308
Self-citationKonstan, M. W., Davis, P. B., Wagener, J. S., Hilliard, K. A., Stern, R. C., Milgram, L. J. H., Kowalczyk, T. H., Hyatt, S. L., Fink, T. L., Gedeon, C. R., et al. (2004) · Human Gene Therapy · doi:10.1089/hum.2004.15.1255 · Cited by 298
Functional, Persistent, and Extended Liver to Pancreas Transdifferentiation
Ber, I., Keren Shternhall-ron, A., Perl, S., Ohanuna, Z., Goldberg, I., Barshack, I., Benvenisti-Zarum, L., Meivar‐Levy, I., & Ferber, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303127200 · Cited by 264
Silencing of episomal transgene expression by plasmid bacterial DNA elements in vivo
Chen, Z. Y., He, C. Y., Meuse, L. A., & Kay, M. A. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302231 · Cited by 232
Adeno-Associated Virus Technologies and Methods for Targeted Neuronal Manipulation
Haery, L., Deverman, B. E., Matho, K. S., Cetin, A. H., Woodard, K., Cepko, C. L., Guerin, K. I., Rego, M. A., Ersing, I., Bächle, S. M., et al. (2019) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2019.00093 · Cited by 220
Developing MR reporter genes: promises and pitfalls
Gilad, A. A., Winnard, P. T., van Zijl, P. C. M., & Bulte, J. W. M. (2007) · NMR in Biomedicine · doi:10.1002/nbm.1134 · Cited by 189
Gene therapy progress and prospects: cystic fibrosis
Uta Griesenbach, D., Geddes, D. M., & Alton, E. W. F. W. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302809 · Cited by 174
Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Papadakis, E. D., Nicklin, S. A., Baker, A. H., & White, S. J. (2004) · Current Gene Therapy · doi:10.2174/1566523044578077 · Cited by 175
Poliner, E., Pulman, J. A., Zienkiewicz, K., Childs, K. L., Benning, C., & Farré, E. M. (2017) · Plant Biotechnology Journal · doi:10.1111/pbi.12772 · Cited by 169
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
Ferrari, S., Geddes, D. M., & Alton, E. W. F. W. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00145-x · Cited by 166
Chen, Z.-Y., Riu, E., He, C.-Y., Xu, H., & Kay, M. A. (2008) · Molecular Therapy · doi:10.1038/sj.mt.6300399 · Cited by 160
Non-Invasive Detection of a Small Number of Bioluminescent Cancer Cells In Vivo
Kim, J., Urban, K., Cochran, E. D., Lee, S., Ang, A., Rice, B., Bata, A., Campbell, K. D., Coffee, R. J., Gorodinsky, A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009364 · Cited by 159
Gene transfer to the lung: Lessons learned from more than 2 decades of CF gene therapy
Uta Griesenbach, D., & Alton, E. W. F. W. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.09.010 · Cited by 164
Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Alton, E. W. F. W., Beekman, J. M., Boyd, A. C., Brand, J., Carlon, M. S., Connolly, M. M., Chan, M., Conlon, S., Davidson, H. E., Davies, J. C., et al. (2017) · Thorax · doi:10.1136/thoraxjnl-2016-208406 · Cited by 150
Self-citationMultilineage Cells from Adipose Tissue as Gene Delivery Vehicles
Morizono, K., Ugarte, D. A. D., Zhu, M. P., Zuk, P., Elbarbary, A. S., Ashjian, P. H., Benhaim, P., Chen, I. S. Y., & Hedrick, M. H. (2003) · Human Gene Therapy · doi:10.1089/10430340360464714 · Cited by 146
The University of North Carolina at Chapel Hill University Libraries (2015) · PubMed · doi:10.17615/2x9m-k248 · Cited by 159
DNA vaccines: improving expression of antigens
Garmory, H. S., Brown, K. A., & Titball, R. W. (2003) · Genetic Vaccines and Therapy · doi:10.1186/1479-0556-1-2 · Cited by 143
Intranasal gene delivery with a polyethylenimine–PEG conjugate
Kichler, A., Chillón, M., Leborgne, C., Danos, O., & Frisch, B. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(02)00080-9 · Cited by 131
Systemic delivery of mRNA and DNA to the lung using polymer-lipid nanoparticles
Kaczmarek, J. C., Patel, A. K., Rhym, L. H., Palmiero, U. C., Bhat, B., Heartlein, M. W., DeRosa, F., & Anderson, D. G. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120966 · Cited by 110
Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration
Bertoni, C., Jarrahian, S., Wheeler, T. M., Li, Y., Olivares, E. C., Calos, M. P., & Rando, T. A. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504505102 · Cited by 107
Gene insertion and long-term expression in lung mediated by the sleeping beauty transposon system
Belur, L. R., Frandsen, J. L., Dupuy, A. J., Ingbar, D. H., Largaespada, D. A., Hackett, P. B., & McIvor, R. S. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00211-9 · Cited by 105
McLachlan, G., Davidson, H. M., Holder, E. L., Davies, L. A., Pringle, I. A., Jones, S., Baker, A., Tennant, P. A., Gordon, C., Vrettou, C., et al. (2011) · Gene Therapy · doi:10.1038/gt.2011.55 · Cited by 104
Self-citationGorelik, J., Shevchuk, A., Ramalho, M., Elliott, M., Lei, C., Higgins, C. F., Lab, M. J., Klenerman, D., Krauzewicz, N., & Korchev, Y. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252458399 · Cited by 103
Self-citationNovel Minicircle Vector for Gene Therapy in Murine Myocardial Infarction
Huang, M., Chen, Z., Hu, S., Jia, F., Li, Z., Hoyt, G. E., Robbins, R. C., Kay, M. A., & Wu, J. C. (2009) · Circulation · doi:10.1161/circulationaha.108.841155 · Cited by 99
Dullaers, M., Meirvenne, S. V., Heirman, C., Straetman, L., Bonehill, A., Aerts, J. L., Thielemans, K., & Breckpot, K. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302697 · Cited by 102
piggyBac Transposon-mediated Long-term Gene Expression in Mice
Nakanishi, H., Higuchi, Y., Kawakami, S., Yamashita, F., & Hashida, M. (2010) · Molecular Therapy · doi:10.1038/mt.2009.302 · Cited by 97
Buck, T., & Wijnholds, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21124197 · Cited by 92
“(TATA box, Inr, MTE and DPE) [48] EF1-α 2500 Ubiquitous, ++ [51,70] PGK 426 Ubiquitous, ++ [53] UbC 403 Ubiquitous, ++ [70]”
Gene transfer of hepatocyte growth factor by electroporation reduces bleomycin-induced lung fibrosis
Gazdhar, A., Fachinger, P., van Leer‐Buter, C., Pieróg, J., Gugger, M., Friis, R. R., Schmid, R. A., & Geiser, T. (2006) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00082.2006 · Cited by 92
Novel molecular approaches to cystic fibrosis gene therapy
LEE, T. W. R., Matthews, D. A., & Blair, G. E. (2005) · Biochemical Journal · doi:10.1042/bj20041923 · Cited by 90
CMV enhancer/human PDGF-β promoter for neuron-specific transgene expression
Liu, B., Wang, X., Ma, Y. X., & Wang, S. (2003) · Gene Therapy · doi:10.1038/sj.gt.3302126 · Cited by 89
Kaufman, W. L., Kocman, I., Agrawal, V., Rahn, H.-P., Besser, D., & Gossen, M. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn508 · Cited by 93
Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo
Xenariou, S., Uta Griesenbach, D., Ferrari, S., Dean, P., Scheule, R. K., Cheng, S. H., Geddes, D. M., Plank, C., & Alton, E. W. F. W. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302803 · Cited by 87
Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing
Maule, G., Casini, A., Montagna, C., Ramalho, A. S., De Boeck, K., Debyser, Z., Carlon, M. S., Petris, G., & Cereseto, A. (2019) · Nature Communications · doi:10.1038/s41467-019-11454-9 · Cited by 86
Wang, X.-Y., Xu, Z.-J., Tian, Z., Zhang, X., Xu, D., Li, Q., Zhang, J., & Wang, T. (2017) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13216 · Cited by 84
Long-term Transgene Expression in the Central Nervous System Using DNA Nanoparticles
Yurek, D. M., Fletcher, A. M., Smith, G. M., Seroogy, K. B., Ziady, A. G., Molter, J. P., Kowalczyk, T. H., Padegimas, L., & Cooper, M. J. (2009) · Molecular Therapy · doi:10.1038/mt.2009.2 · Cited by 79
Enhanced Lung Gene Expression After Aerosol Delivery of Concentrated pDNA/PEI Complexes
Davies, L. A., McLachlan, G., Jones, S., Ferguson, D. J. P., Baker, A., Tennant, P. A., Gordon, C., Vrettou, C., Baker, E., Zhu, J., et al. (2008) · Molecular Therapy · doi:10.1038/mt.2008.96 · Cited by 79
Self-citationPostintegrative Gene Silencing within the Sleeping Beauty Transposition System
Garrison, B. S., Yant, S. R., Mikkelsen, J. G., & Kay, M. A. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00498-07 · Cited by 78
Moving forward: cystic fibrosis gene therapy
Uta Griesenbach, D., & Alton, E. W. F. W. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt372 · Cited by 76
Suzuki, M., Kasai, K., & Saeki, Y. (2006) · Journal of Virology · doi:10.1128/jvi.80.7.3293-3300.2006 · Cited by 75
Yurek, D. M., Fletcher‐Turner, A., Kowalczyk, T. H., Padegimas, L., & Cooper, M. J. (2009) · Cell Transplantation · doi:10.3727/096368909x12483162196881 · Cited by 74
Efficient suppression of endogenous CFTR nonsense mutations using anticodon-engineered transfer RNAs
Ko, W., Porter, J. J., Sipple, M. T., Edwards, K. M., & Lueck, J. D. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.04.033 · Cited by 72
Minicircle DNA Provides Enhanced and Prolonged Transgene Expression Following Airway Gene Transfer
Munye, M. M., Tagalakis, A. D., Barnes, J. L., Brown, R. E., McAnulty, R. J., Howe, S. J., & Hart, S. L. (2016) · Scientific Reports · doi:10.1038/srep23125 · Cited by 72
Gene therapy for cystic fibrosis lung disease: current status and future perspectives.
Rosenecker, J., Huth, S., & Rudolph, C. (2006) · PubMed · Cited by 72
Therapeutic promise of engineered nonsense suppressor tRNAs
Porter, J. J., Heil, C. S., & Lueck, J. D. (2021) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1641 · Cited by 73
Polyethylenimine-mediated gene delivery to the lung and therapeutic applications
Conese, M. (2008) · Drug Design Development and Therapy · doi:10.2147/dddt.s2708 · Cited by 71
Abdallah, B. M., Ding, M. L., Jensen, C. H., Ditzel, N., Flyvbjerg, A., Jensen, T. G., Dagnæs‐Hansen, F., Gasser, J. A., & Kassem, M. S. (2007) · Endocrinology · doi:10.1210/en.2007-0171 · Cited by 69
Gene and cell therapy for cystic fibrosis: From bench to bedside
Conese, M., Ascenzioni, F., Boyd, A., Coutelle, C., Fino, I. D., Smedt, S. C. D., Rejman, J., Rosenecker, J., Schindelhauer, D., & Scholte, B. J. (2011) · Journal of Cystic Fibrosis · doi:10.1016/s1569-1993(11)60017-9 · Cited by 71
Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver
Argyros, O., Wong, S. P., Fedonidis, C., Tolmachov, O. E., Waddington, S. N., Howe, S. J., Niceta, M., Coutelle, C. C., & Harbottle, R. P. (2011) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0713-3 · Cited by 68
Nonviral gene transfer to skeletal, smooth, and cardiac muscle in living animals
Dean, D. A. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00613.2004 · Cited by 67
Bianchi, M., Crinelli, R., Giacomini, E., Carloni, E., & Magnani, M. (2009) · Gene · doi:10.1016/j.gene.2009.08.013 · Cited by 70
Gene Therapy Progress and Prospects: Cystic fibrosis
Uta Griesenbach, D., Ferrari, S., Geddes, D. M., & Alton, E. W. F. W. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301791 · Cited by 67
Mitsui, M., Nishikawa, M., Zang, L., Ando, M., Hattori, K., Takahashi, Y., Watanabe, Y., & Takakura, Y. (2009) · The Journal of Gene Medicine · doi:10.1002/jgm.1317 · Cited by 63
Papapetrou, E. P., Zoumbos, N. C., & Athanassiadou, A. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302626 · Cited by 63
Ho, S. C. L., Mariati, Yeo, J. H. M., Fang, S. G., & Yang, Y. (2014) · Molecular Biotechnology · doi:10.1007/s12033-014-9809-2 · Cited by 62
Use of ultrasound to enhance nonviral lung gene transfer in vivo
Xenariou, S., Uta Griesenbach, D., Liang, H.-D., Zhu, J., Farley, R., Somerton, L., Singh, C., Jeffery, P. K., Ferrari, S., Scheule, R. K., et al. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302922 · Cited by 58
Gene therapy for cystic fibrosis: an example for lung gene therapy
Uta Griesenbach, D., Geddes, D. M., & Alton, E. W. F. W. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302368 · Cited by 57
Aerosol Delivery of DNA/Liposomes to the Lung for Cystic Fibrosis Gene Therapy
Davies, L. A., Nunez-Alonso, G. A., McLachlan, G., Hyde, S. C., & Gill, D. R. (2014) · Human Gene Therapy Clinical Development · doi:10.1089/hum.2014.019 · Cited by 56
Self-citationPassport , a native Tc1 transposon from flatfish, is functionally active in vertebrate cells
Clark, K. J., Carlson, D. F., Leaver, M. J., Foster, L. K., & Fahrenkrug, S. C. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkn1025 · Cited by 56
Alton, E. W. F. W., Boyd, A., Porteous, D. J., Davies, G., Davies, J. C., Uta Griesenbach, D., Higgins, T., Gill, D. R., Hyde, S. C., & Innes, J. A. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1193le · Cited by 61
Self-citationIn Vivo Electroporation Mediated Gene Delivery to the Beating Heart
Ayuni, E., Gazdhar, A., Giraud, M., Kadner, A., Gugger, M., Cecchini, M. G., Caus, T., Carrel, T. P., Schmid, R. A., & Tevaearai, H. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014467 · Cited by 55
Boylan, N. J., Kim, A. J., Suk, J. S., Adstamongkonkul, P., Simons, B. W., Lai, S. K., Cooper, M. J., & Hanes, J. S. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.080 · Cited by 54
DeGiulio, J. V., Kaufman, C. D., & Dean, D. A. (2010) · Gene Therapy · doi:10.1038/gt.2009.166 · Cited by 52
Avilés, M. O., Lin, C.-H., Zelivyanskaya, M. L., Graham, J. G., Boehler, R. M., Messersmith, P. B., & Shea, L. D. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.10.035 · Cited by 52
Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver
Al-Dosari, M. S., Zhang, G., Knapp, J. E., & Liu, D. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.11.063 · Cited by 52
New organs from our own tissues: liver-to-pancreas transdifferentiation
Meivar‐Levy, I., & Ferber, S. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.10.006 · Cited by 52
Dullaers, M., & Thielemans, K. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.846 · Cited by 52
Lee, C. I., Kohn, D. B., Ekert, J. E., & Tarantal, A. F. (2003) · Molecular Therapy · doi:10.1016/j.ymthe.2003.09.019 · Cited by 50
Gene Transfer into the Lung by Nanoparticle Dextran-Spermine/Plasmid DNA Complexes
Abdullah, S., Wendy-Yeo, W. Y., Hosseinkhani, H., Hosseinkhani, M., Masrawa, E., Ramasamy, R., Rosli, R., Rahman, S. A., & Domb, A. J. (2010) · BioMed Research International · doi:10.1155/2010/284840 · Cited by 53
The development of gene therapy for diseases of the lung
Gill, D. R., Davies, L. A., Pringle, I. A., & Hyde, S. C. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3317-z · Cited by 50
Self-citationOptimising non-viral gene delivery in a tumour spheroid model
Mellor, H. R., Davies, L. A., Caspar, H., Pringle, C. R., Hyde, S. C., Gill, D. R., & Callaghan, R. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.947 · Cited by 49
Self-citationPlasmid DNA Production for Therapeutic Applications
Lara, A. R., & Ramı́rez, O. T. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-433-9_14 · Cited by 49
Hypoxia-specific gene expression for ischemic disease gene therapy
Kim, H., Mahato, R. I., & Lee, M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.009 · Cited by 48
Riu, E., Grimm, D., Huang, Z., & Kay, M. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.558 · Cited by 54
Hsu, C. Y. M., & Uludağ, H. (2012) · Journal of drug targeting · doi:10.3109/1061186x.2012.655247 · Cited by 47
Zhou, R., Norton, J. E., Zhang, N., & Dean, D. A. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302936 · Cited by 46
Davies, L. A., Hyde, S. C., Nunez-Alonso, G. A., Bazzani, R. P., Harding-Smith, R., Pringle, I. A., Lawton, A. E., Abdullah, S., Roberts, T. C., McCormick, D., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.04.019 · Cited by 45
Self-citationA Comparative Analysis of Constitutive Promoters Located in Adeno-Associated Viral Vectors
Damdindorj, L., Karnan, S., Ota, A., Hossain, E., Konishi, Y., Hosokawa, Y., & Konishi, H. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106472 · Cited by 54
Bell, J. B., Aronovich, E. L., Schreifels, J. M., Beadnell, T. C., & Hackett, P. B. (2010) · Molecular Therapy · doi:10.1038/mt.2010.152 · Cited by 45
Controlling the kinetics of transgene expression by plasmid design
Yew, N. S. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.12.009 · Cited by 43
Pringle, I. A., McLachlan, G., Collie, D., Jones, S., Lawton, A. E., Tennant, P. A., Baker, A., Gordon, C., Blundell, R. J., Varathalingam, A., et al. (2007) · The Journal of Gene Medicine · doi:10.1002/jgm.1026 · Cited by 43
Self-citationThioredoxin prevents the development and progression of elastase-induced emphysema
Kinoshita, T., Hoshino, T., Imaoka, H., Ichiki, H., Okamoto, M., Kawayama, T., Yodoi, J., Kato, S., & Aizawa, H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.01.053 · Cited by 43
Nonionic Amphiphilic Block Copolymers Promote Gene Transfer to the Lung
Desigaux, L., Gourden, C., Bello-Roufaı̈, M., Richard, P., Oudrhiri, N., Lehn, P., Escande, D., Pollard, H., & Pitard, B. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.821 · Cited by 43
Non-viral vectors in cystic fibrosis gene therapy: recent developments and future prospects
Pringle, I. A., Hyde, S. C., & Gill, D. R. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590903055029 · Cited by 44
Self-citationLindberg, M. F., Gall, T. L., Carmoy, N., Berchel, M., Hyde, S. C., Gill, D. R., Jaffrès, P., Lehn, P., & Montier, T. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.04.024 · Cited by 41
Self-citationGazdhar, A., Bilici, M., Pieróg, J., Ayuni, E., Gugger, M., Wetterwald, A., Cecchini, M. G., & Schmid, R. A. (2006) · The Journal of Gene Medicine · doi:10.1002/jgm.911 · Cited by 41
Detection of plasmid DNA vectors following gene transfer to the murine airways
Pringle, I. A., Raman, S., Sharp, W. W., Cheng, S. H., Hyde, S. C., & Gill, D. R. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302518 · Cited by 41
Self-citationAlméciga-Díaz, C. J., Montaño, A. M., Tomatsu, S., & Barrera, L. A. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07769.x · Cited by 41
Electrohydrodynamic Comminution: A Novel Technique for the Aerosolisation of Plasmid DNA
Davies, L. A., Hannavy, K., Davies, N., Pirrie, A., Coffee, R., Hyde, S. C., & Gill, D. R. (2005) · Pharmaceutical Research · doi:10.1007/s11095-005-5268-6 · Cited by 40
Self-citationPfeifer, C., Hasenpusch, G., Üzgün, S., Aneja, M. K., Reinhardt, D., Kirch, J., Schneider, M., Claus, S., Frieß, W., & Rudolph, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.05.006 · Cited by 39
HIV Infects Bronchial Epithelium and Suppresses Components of the Mucociliary Clearance Apparatus
Chinnapaiyan, S., Parira, T., Dutta, R. K., Agudelo, M., Morris, A. M., Nair, M., & Unwalla, H. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169161 · Cited by 39
Electroporation of the Vasculature and the Lung
Dean, D. A. (2003) · DNA and Cell Biology · doi:10.1089/104454903322625000 · Cited by 39
Ostrowski, L. E., Yin, W., Diggs, P. S., Rogers, T. D., O’Neal, W. K., & Grubb, B. R. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302994 · Cited by 37
Rose, A. C., Goddard, C. A., Colledge, W. H., Cheng, S. H., Gill, D. R., & Hyde, S. C. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301792 · Cited by 37
Self-citationRole for Centromeric Heterochromatin and PML Nuclear Bodies in the Cellular Response to Foreign DNA
Bishop, C. L., Ramalho, M., Nadkarni, N. A., Kong, W. M., Higgins, C. F., & Krauzewicz, N. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.26.7.2583-2594.2006 · Cited by 36
Self-citationLong-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways
Jones, S., Davies, L. A., Varathalingam, A., Gill, D. R., & Hyde, S. C. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302815 · Cited by 36
Self-citationKatz, R. A., Jack-Scott, E., Narezkina, A., Palagin, I. S., Boimel, P. J., Kulkosky, J., Nicolas, É., Greger, J., & Skalka, A. M. (2007) · Journal of Virology · doi:10.1128/jvi.01643-06 · Cited by 36
Non-viral gene transfer therapy for cystic fibrosis
Ziady, A. G., Davis, P. B., & Konstan, M. W. (2003) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.3.3.449 · Cited by 37
Metadata
- Authors
- Gill, D., Smyth, S., Goddard, C., Pringle, I., Higgins, C., Colledge, W., & Hyde, S.
- Affiliations
- John Radcliffe Hospital (GB)
- University of Cambridge (GB)
- Hammersmith Hospital (GB)
- Venue
- Gene Therapy
- Published
- 2001-10-01
- Volume
- 8
- Issue
- 20
- Pages
- 1539-1546
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2122003649
- Cited by
- 214
- References
- 34
- Citations by year
- 2026: 6 · 2025: 4 · 2024: 1 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 6 · 2014: 9 · 2013: 7 · 2012: 12
- FWCI
- 3.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust
- Cystic Fibrosis Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Animal Genetics and Reproduction
- Keywords
- persistent transgene expression, pulmonary gene therapy, promoter selection, cystic fibrosis, promoter silencing, reporter gene expression
- MeSH terms
- Administration, Inhalation, Animals, Avian Sarcoma Viruses, Cell Line, Cystic Fibrosis, Cytomegalovirus, Female, Gene Expression Regulation, Genetic Vectors, Humans, Luciferases, Lung, Mice, Inbred BALB C, Plasmids, Promoter Regions, Genetic, Simian virus 40, Time Factors, Genetic Therapy, Statistics, Nonparametric, Transgenes, Peptide Elongation Factor 1, Models, Animal, Ubiquitin C, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review